Publications by authors named "Knut Robert Andersen"

Claim this Profile
B
Baseline characteristics of patients enrolled in the EMPACT-MI trial.
Josephine Harrington, Jacob A Udell, W Schuyler Jones, Stefan D Anker, Deepak L Bhatt, Knut Robert Andersen

Eur J Heart Fail· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.
Mark A Espeland, Richard E Pratley, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Knut Robert Andersen

Diabetes Obes Metab· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.
Martin Ridderstråle, Knut Robert Andersen, Cordula Zeller, Gabriel Kim, Hans J Woerle

Lancet Diabetes Endocrinol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis